Clinical Aspects and Diagnosis of Anaphylaxis

  • Phil Lieberman
Part of the Allergy Frontiers book series (ALLERGY, volume 4)

Anaphylaxis is an acute systemic event which can be rapidly progressive and fatal. Most cases are mediated by IgE related mechanisms. However, episodes of anaphylaxis can occur through other immunologic and non-immunologic pathways. Therefore it is defined by its clinical manifestations. Those manifestations can be protean highly variable. Four systems can be involved. These are the skin and subcutaneous tissue, the respiratory tract, the gastrointestinal tract, and the blood vessels throughout the body.

The most common system involved is the skin. Cutaneous manifestations occur in approximately 90 percent or more of episodes. The next most frequent system involved is the respiratory tract, followed by the gastrointestinal tract. In some cases, patients manifest only symptoms caused by involvement of the systemic vasculature, thus presenting as shock.

In spite of the mechanism involved or the manifestations of the event, the initial treatment of choice is the same. Epinephrine is the initial drug of choice for all episodes. Numerous conditions must be considered in the differential diagnosis. Perhaps the most common of these is the vasodepressor (vasovagal) response.


Allergy Clin Immunol Systemic Mastocytosis World Allergy Organization Monosodium Glutamate Hereditary Angioedema 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sampson HA, Munoz-Furlong A, Bock SA, et al. (2005) Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 115(3):584–592PubMedCrossRefGoogle Scholar
  2. 2.
    Sampson HA, Munoz-Furlong A, Campbell RL, et al. (2006) Second symposium on the definition and management of anaphylaxis: summary report — Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol 117(2):391–397PubMedCrossRefGoogle Scholar
  3. 3.
    Lieberman P, Kemp S, Oppenheimer J, et al. (2005) The diagnosis and management of anaphy-laxis: an updated practice parameter. J Allergy Clin Immunol 115:S483–S523 (supplement)CrossRefGoogle Scholar
  4. 4.
    Lieberman P (1998) Anaphylaxis and anaphylactoid reactions. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW (eds.), Allergy: Principles and Practice, Vol. 2, 5th edition. St. Louis, MO: Mosby-Yeark, Section E Chapter 77, pp. 1079–1092Google Scholar
  5. 5.
    Johansson SGO, Bieber T, Dahl R, et al. (2004) Revised nomenclature for allergy for global use: report of the nomenclature review committee of the World Allergy Organization October 2003. J Allergy Clin Immunol 113:832–836PubMedCrossRefGoogle Scholar
  6. 6.
    Lieberman PL, Camargo C, Simons FER, Jick H, Sheikh A, Bohlke K, Miller R (2006) Epidemiology of anaphylaxis: findings of the ACAAI (American College of Asthma, Allergy, and Immunology) epidemiology of anaphylaxis working group. Ann Allergy Asthma Immunol 97:596–602PubMedGoogle Scholar
  7. 7.
    Simons FER, Peterson S, Black CD (2002) Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 110:647–651PubMedCrossRefGoogle Scholar
  8. 8.
    Gupta R, Sheikh A, Strachan D, et al. (2003) Increasing hospital admissions for systemic allergic disorders in England: analysis of national admission data. BMJ 327:1142–1143PubMedCrossRefGoogle Scholar
  9. 9.
    Moneret-Vautrin DA, Morisset M, Flabbee J, et al. (2005) Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 60:443–451PubMedCrossRefGoogle Scholar
  10. 10.
    Warner JO (2007) Anaphylaxis: the latest allergy epidemic. Pediatr Allergy Immunol 18:1–2PubMedCrossRefGoogle Scholar
  11. 11.
    Gupta R, Sheikh A, Strachand P, et al. (2004) Burden of allergic disease in the UK: secondary analysis of national databases. Clin Exp Allergy 34:520–526PubMedCrossRefGoogle Scholar
  12. 12.
    Sicherer SH, Leung D (2004) Advances in allergic skin disease, anaphylaxis, and hypersensi-tivity reactions to foods, drugs, and insect stings. J Allergy Clin Immunol 114:118–124PubMedCrossRefGoogle Scholar
  13. 13.
    Sicherer SH, Sampson HA (2006) Food allergy. J Allergy Clin Immunol 117:S470–S475 (supplement)PubMedCrossRefGoogle Scholar
  14. 14.
    Sheikh A, Alves B (2001) Age, sex, geographical and socioeconomic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp Allergy 31:1571–1576PubMedCrossRefGoogle Scholar
  15. 15.
    Camargo Jr CA, Clark S, Kaplan MS, et al. (2006) Regional differences in EpiPen prescriptions in the United States. J Allergy Clin Immunol 117:S307 (abstract)Google Scholar
  16. 16.
    Simons FER, Peterson S, Black C (2001) Epinephrine dispensing for out-of-hospital treatment of anaphylaxis in infants and children: a population-based study. Ann Allergy Asthma Immunol 86:622–626PubMedGoogle Scholar
  17. 17.
    Webb L, Lieberman P (2006) Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 97:39–43PubMedCrossRefGoogle Scholar
  18. 18.
    Hamann CP (1993) Natural rubber latex protein sensitivity. Rev Am J Contact Dermatitis 14:4–21Google Scholar
  19. 19.
    Soreide E, Busrod T, Harboe S (1988). Severe anaphylactic reactions outside hospital; etiology, symptoms, and treatment. Acta Anaesthesiol Scand 32:339–344PubMedCrossRefGoogle Scholar
  20. 20.
    Simons FER, Chad ZH, Gold M (2004) Anaphylaxis in children. Allergy Clin Immunol Int: J World Allergy Org Supplement 1: 242–244Google Scholar
  21. 21.
    Braganza SC, Acworth JP, Mckinnon DR, et al. (2006) Pediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 91(2):159–163PubMedCrossRefGoogle Scholar
  22. 22.
    Brown SG, Blackman KE, Stenlake V, et al. (2004) Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 21(2):149–154PubMedCrossRefGoogle Scholar
  23. 23.
    Kounis NG (2006) Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm. Int J Cardiol 110(1):7–14PubMedCrossRefGoogle Scholar
  24. 24.
    DeSouza RL, Short T, Warman GR, et al. (2004) Anaphylaxis associated with fibrinolysis, reversed with tranexamic acid and demonstrated by thromboelastography. Anaesth Intens Care 32(4):580–587Google Scholar
  25. 25.
    Sampson HA (2001) Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 107(5):891–896PubMedCrossRefGoogle Scholar
  26. 26.
    Lieberman P (2005) Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 95:217–228PubMedCrossRefGoogle Scholar
  27. 27.
    Caughey GH (2006) Tryptase genetics and anaphylaxis. J Allergy Clin Immunol 117(6):1411–1414PubMedCrossRefGoogle Scholar
  28. 28.
    Lin RY, Schwartz LB, Curry A, et al. (2000) Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J Allergy Clin Immunol 106 (1 Pt 1):65–71PubMedCrossRefGoogle Scholar
  29. 29.
    Ebo DG, Hagendorens MM, Bridts CH, et al. (2004) In vitro allergy diagnosis: should we follow the flow? Clin Exp Allergy 34(3):332–339PubMedCrossRefGoogle Scholar
  30. 30.
    Zhou X, Buckley MG, Lau LC, et al. (2006) Mast cell carboxypeptidase as a new clinical marker for anaphylaxis. J Allergy Clin Immunol 117(2):S85CrossRefGoogle Scholar
  31. 31.
    Rolla G, Nebiolo F, Guida G, et al. (2006) Level of exhaled nitric oxide during anaphylaxis. Ann Allergy Asthma Immunol 97:264–265PubMedGoogle Scholar
  32. 32.
    Lin RY, Gupta A (2003) Nitric oxide levels in patients with acute allergic reactions. J Allergy Clin Immunol 111:S100 (abstract)CrossRefGoogle Scholar
  33. 33.
    Schwartz LB (2006) Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin N Am 26:451–463CrossRefGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Phil Lieberman
    • 1
  1. 1.Division of Allergy and Immunology, Departments of Medicine and PediatricsUniversity of TennesseeMemphisUSA

Personalised recommendations